OPUS
Suzhou
About OPUS
OPUS develops clinically applicable tissue engineering products and treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $1.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2022)
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/opus-198949 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.